Arkansas State University
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1909-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.astate.edu
Effect of Lubiprostone on Nutritional Status and Pulmonary Function in Adults With Cystic Fibrosis
Terminated
- Conditions
- ConstipationCystic FibrosisNutrition
- First Posted Date
- 2007-12-20
- Last Posted Date
- 2015-03-04
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 7
- Registration Number
- NCT00577499
Nutritional Risk and Mucositis in Patients With Head and Neck Carcinoma Receiving Chemoradiation
Completed
- Conditions
- Head and Neck Cancer
- Interventions
- Other: Observation
- First Posted Date
- 2007-12-20
- Last Posted Date
- 2016-02-09
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 37
- Registration Number
- NCT00577902
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Effects of Exercise in Combination With Epoetin Alfa
Not Applicable
Completed
- Conditions
- Multiple Myeloma
- Interventions
- Behavioral: ExerciseDrug: Total Therapy IIBiological: Autologous Peripheral Blood Stem Cell TransplantationBiological: Red Blood Cell TransfusionDrug: Heparin, Low-Molecular-WeightBiological: Platelet Transfusion
- First Posted Date
- 2007-12-19
- Last Posted Date
- 2015-04-06
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 120
- Registration Number
- NCT00577096
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Hydralazine as a Demethylating Agent in Rectal Cancer
- First Posted Date
- 2007-12-18
- Last Posted Date
- 2015-03-04
- Lead Sponsor
- University of Arkansas
- Registration Number
- NCT00575640
Hydralazine as Demethylating Agent in Breast Cancer
- First Posted Date
- 2007-12-18
- Last Posted Date
- 2015-03-04
- Lead Sponsor
- University of Arkansas
- Registration Number
- NCT00575978
Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation
Phase 2
Completed
- Conditions
- Breast Cancer
- Interventions
- Procedure: Sentinel Node Biopsy
- First Posted Date
- 2007-12-18
- Last Posted Date
- 2016-10-27
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 699
- Registration Number
- NCT00575744
- Locations
- 🇺🇸
University of Arkansas For Medical Sciences, Little Rock, Arkansas, United States
Adrenal Suppression and Adrenal Recovery Induced by Megestrol Acetate
- First Posted Date
- 2007-12-17
- Last Posted Date
- 2011-08-29
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 7
- Registration Number
- NCT00575029
- Locations
- 🇺🇸
University of Arkansas For Medical Sciences, Little Rock, Arkansas, United States
Percutaneous Removal and Margin Ablation for Breast Cancer
Phase 1
Completed
- Conditions
- Breast Cancer
- Interventions
- Procedure: Percutaneous Removal and Margin Ablation
- First Posted Date
- 2007-12-17
- Last Posted Date
- 2013-07-25
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 32
- Registration Number
- NCT00574301
- Locations
- 🇺🇸
University of Arkansas For Medical Sciences, Little Rock, Arkansas, United States
Analyzing the Composition of Tears to Identify Cancer
Phase 1
Completed
- Conditions
- Ovarian CancerBenign DiseaseBreast CancerColon Cancer
- Interventions
- Other: Tear collection
- First Posted Date
- 2007-12-17
- Last Posted Date
- 2021-08-05
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 150
- Registration Number
- NCT00574678
- Locations
- 🇺🇸
University of Arkansas For Medical Sciences, Little Rock, Arkansas, United States
Study of Multiple Myeloma Patients Relapsing or Progressing After Autologous Transplantation on Total Therapy 2
Phase 3
Terminated
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2007-12-14
- Last Posted Date
- 2011-08-12
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 5
- Registration Number
- NCT00573391
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
© Copyright 2025. All Rights Reserved by MedPath